ARID1A mutation in blastic plasmacytoid dendritic cell neoplasm
ARID1A mutation in blastic plasmacytoid dendritic cell neoplasm
复制标题
母细胞性浆细胞样树突状细胞肿瘤中的 ARID1A 突变
DOI:
10.3324/haematol.2017.172742
复制
发表时间:
2017-11
期刊:
影响因子:
--
通讯作者:
Jin J
中科院分区:
文献类型:
--
作者:
Wang Lei;Yang Min;Zhang Xiang;Yang Chunmei;Jin Jie;Wang Lei;Yang Min;Zhang Xiang;Yang Chunmei;Huang Xin;Jin Jie;Wang Lei;Yang Min;Zhang Xiang;Yang Chunmei;Huang Xin;Jin Jie;Wang Zhaoming;Jin J;Jin J;Jin J
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive hematologic disease originating from plasmacytoid dendritic cell precursors.[1][1] According to the WHO 2008 classification of hematopoietic tumors, BPDCN belongs to the category “acute myeloid leukemia (AML) and related
登录
查看更多内容
影响因子:
30.8
作者:
Kadoch, Cigall;Hargreaves, Diana C.;Hodges, Courtney;Elias, Laura;Ho, Lena;Ranish, Jeff;Crabtree, Gerald R.
通讯作者:
Crabtree, Gerald R.
影响因子:
3.5
作者:
Herling, Marco;Jones, Dan
通讯作者:
Jones, Dan
影响因子:
11.4
作者:
Menezes, J.;Acquadro, F.;Cigudosa, J.
通讯作者:
Cigudosa, J.
影响因子:
4.8
作者:
Pagan, Julia K.;Arnold, Jeremy;Khanna, Kum Kum
通讯作者:
Khanna, Kum Kum
影响因子:
16.6
作者:
通讯作者:
--